array(3) { ["company_details"]=> array(13) { ["name"]=> string(35) "Tekla Healthcare Opportunities Fund" ["slug"]=> string(44) "e8566-us-tekla-healthcare-opportunities-fund" ["logo"]=> NULL ["description"]=> string(983) "Tekla Healthcare Opportunities Fund is a non-diversified closed-end fund. The Fund's investment objective is to seek current income and long-term capital appreciation through investments in the United States and non-United States companies in the healthcare industry, including equity securities, debt securities and pooled investment vehicles. It invests primarily in securities of public and private companies. It focuses on investing in private companies and other restricted securities, including private investments in public equity and venture capital investments, if these securities would comprise approximately 10% or less of managed assets. It invests in sub-sectors, such as biotechnology, healthcare equipment and supplies, healthcare providers and services, healthcare technology, life sciences tools and services, pharmaceuticals, real estate investment trusts, real estate management and development. Tekla Capital Management LLC is the investment advisor of the Fund." ["address_street"]=> string(17) "2 Liberty Sq FL 9" ["address_place"]=> string(6) "Boston" ["address_region"]=> string(13) "Massachusetts" ["founding_date"]=> string(10) "2014-01-26" ["website_domain"]=> string(12) "teklacap.com" ["website_url"]=> string(24) "https://www.teklacap.com" ["industry_codes"]=> array(1) { [0]=> string(53) "Trusts, Except Educational, Religious, and Charitable" } ["employee_count"]=> int(2) ["article_count"]=> int(145) } ["articles"]=> array(4) { [0]=> array(7) { ["title_en"]=> string(82) "Lbmc Investment Advisors LLC Acquires 1,287 Shares of Johnson & Johnson (NYSE:JNJ)" ["snippet_en"]=> string(300) "Lbmc Investment Advisors LLC grew its holdings in Johnson & Johnson (NYSE:JNJ - Free Report) by 21.4% in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 7,294 shares of the company's stock after purchasing an additional 1,287 s" ["url"]=> string(73) "https://www.marketbeat.com/instant-alerts/nyse-jnj-sec-filing-2023-09-29/" ["image_url"]=> string(78) "https://images.businessradar.com/articles/28564341-88d3-4b88-b2ed-9009ed96617e" ["source"]=> string(14) "marketbeat.com" ["publication_date"]=> string(10) "2023-09-29" ["categories"]=> array(10) { [0]=> string(11) "Acquisition" [1]=> string(31) "Financial Update/Profit Warning" [2]=> string(24) "Quarterly/Annual Figures" [3]=> string(14) "Issuing Shares" [4]=> string(11) "Regulations" [5]=> string(24) "Stock Research & Ratings" [6]=> string(16) "Share Repurchase" [7]=> string(12) "Stock Market" [8]=> string(18) "General Investment" [9]=> string(19) "Investment Requests" } } [1]=> array(7) { ["title_en"]=> string(91) "Johnson & Johnson (NYSE:JNJ) Shares Purchased by Dominguez Wealth Management Solutions Inc." ["snippet_en"]=> string(219) "Dominguez Wealth Management Solutions Inc. raised its holdings in Johnson & Johnson (NYSE:JNJ – Free Report) by 0.7% during the second quarter, according to the company in its most recent Form 13F filing with the SEC." ["url"]=> string(129) "http://www.defenseworld.net/2023/09/24/johnson-johnson-nysejnj-shares-purchased-by-dominguez-wealth-management-solutions-inc.html" ["image_url"]=> string(78) "https://images.businessradar.com/articles/665b5fd1-ab39-4b4b-9b87-e249a1a0a484" ["source"]=> string(16) "defenseworld.net" ["publication_date"]=> string(10) "2023-09-24" ["categories"]=> array(4) { [0]=> string(11) "Acquisition" [1]=> string(18) "General Investment" [2]=> string(11) "Regulations" [3]=> string(31) "Financial Update/Profit Warning" } } [2]=> array(7) { ["title_en"]=> string(78) "abrdn to Acquire US Specialist Healthcare Closed-End Funds with $3 Billion AUM" ["snippet_en"]=> string(269) "abrdn plc today announced that its U.S. subsidiary abrdn Inc. has entered into an agreement to acquire the healthcare fund management capabilities of Tekla Capital Management LLC (Tekla), a global specialist healthcare investment adviser based in Boston, Massachusetts." ["url"]=> string(84) "https://finance.yahoo.com/news/abrdn-acquire-us-specialist-healthcare-221500989.html" ["image_url"]=> string(78) "https://images.businessradar.com/articles/965c9901-84c5-4864-8fbd-8c2564370b75" ["source"]=> string(9) "yahoo.com" ["publication_date"]=> string(10) "2023-06-20" ["categories"]=> array(3) { [0]=> string(11) "Acquisition" [1]=> string(18) "General Investment" [2]=> string(25) "Business Model Resilience" } } [3]=> array(7) { ["title_en"]=> string(89) "Tekla Healthcare Opportunities Fund Buys Moderna Inc, IDEXX Laboratories Inc, Sarepta ..." ["snippet_en"]=> string(296) "Investment company Tekla Healthcare Opportunities Fund( Current Portfolio) buys Moderna Inc, IDEXX Laboratories Inc, Sarepta Therapeutics Inc, Guardant Health Inc, Icon PLC, sells Anthem Inc, ResMed Inc, Vertex Pharmaceuticals Inc, Amedisys Inc, during the 3-months ended 2021Q3, according to the" ["url"]=> string(86) "https://finance.yahoo.com/news/tekla-healthcare-opportunities-fund-buys-003803939.html" ["image_url"]=> string(78) "https://images.businessradar.com/articles/c8045c8c-3662-40ff-bcea-91667284fcf2" ["source"]=> string(9) "yahoo.com" ["publication_date"]=> string(10) "2021-12-09" ["categories"]=> array(3) { [0]=> string(10) "Litigation" [1]=> string(11) "Acquisition" [2]=> string(18) "General Investment" } } } ["category_annotations"]=> array(25) { [0]=> array(2) { ["name"]=> string(10) "Tax Havens" ["count"]=> int(29) } [1]=> array(2) { ["name"]=> string(18) "General Investment" ["count"]=> int(10) } [2]=> array(2) { ["name"]=> string(12) "Stock Market" ["count"]=> int(7) } [3]=> array(2) { ["name"]=> string(11) "Acquisition" ["count"]=> int(4) } [4]=> array(2) { ["name"]=> string(25) "Business Model Resilience" ["count"]=> int(4) } [5]=> array(2) { ["name"]=> string(16) "Share Repurchase" ["count"]=> int(4) } [6]=> array(2) { ["name"]=> string(10) "Divestment" ["count"]=> int(3) } [7]=> array(2) { ["name"]=> string(11) "Regulations" ["count"]=> int(3) } [8]=> array(2) { ["name"]=> string(13) "Collaboration" ["count"]=> int(2) } [9]=> array(2) { ["name"]=> string(15) "Deals & Tenders" ["count"]=> int(2) } [10]=> array(2) { ["name"]=> string(18) "Business Structure" ["count"]=> int(2) } [11]=> array(2) { ["name"]=> string(19) "Investment Requests" ["count"]=> int(2) } [12]=> array(2) { ["name"]=> string(21) "Shareholders Feedback" ["count"]=> int(2) } [13]=> array(2) { ["name"]=> string(22) "Business Restructuring" ["count"]=> int(2) } [14]=> array(2) { ["name"]=> string(12) "Going Public" ["count"]=> int(1) } [15]=> array(2) { ["name"]=> string(20) "Corporate Governance" ["count"]=> int(1) } [16]=> array(2) { ["name"]=> string(14) "Issuing Shares" ["count"]=> int(1) } [17]=> array(2) { ["name"]=> string(10) "Litigation" ["count"]=> int(1) } [18]=> array(2) { ["name"]=> string(21) "Cultural developments" ["count"]=> int(1) } [19]=> array(2) { ["name"]=> string(24) "Stock Research & Ratings" ["count"]=> int(1) } [20]=> array(2) { ["name"]=> string(13) "Data Security" ["count"]=> int(1) } [21]=> array(2) { ["name"]=> string(20) "Business Development" ["count"]=> int(1) } [22]=> array(2) { ["name"]=> string(16) "Customer Privacy" ["count"]=> int(1) } [23]=> array(2) { ["name"]=> string(31) "Financial Update/Profit Warning" ["count"]=> int(1) } [24]=> array(2) { ["name"]=> string(11) "Slush Funds" ["count"]=> int(1) } } } e8566-us-tekla-healthcare-opportunities-fund